Phototherapy vs. Biological Drug Therapy

Compare the Safety of Ultraviolet Phototherapy vs. Biological Drugs Used for the Treatment of Skin Disease

While biological drug therapies have become popular in the last few years, it is important to evaluate the safety of these medications. Every one of the following drugs has had numerous adverse effects and deaths where the drug was listed as the primary suspected cause.

In contrast, Daavlin’s phototherapy is an extremely safe and effective method of treatment. Even Oxsoralen, a drug used in conjunction with ultraviolet light to create PUVA, has an exemplary safety record.

We invite you to view the statistics of our competitors. Click the links to read FDA statements and other related information.

Adverse Effects

Primary
Suspect
2000-20012002-20032004-20052006-2007Total:
Enbrel10,7212,6334,25421,14038,748
Humira234,1129,8516,57320,559
Remicade3,3575,1845,2324,53718,310
Methotrexate6338887792842,584
Raptiva*4118184711,304*
Elidel325930264628
Protopic705010379302
Oxsoralen (PUVA)30003

Deaths:

Primary
Suspect
2000-20012002-20032004-20052006-2007Total:
Enbrel5103442273111,392
Humira61305203471,003
Remicade3966405053721,913
Methotrexate10912212036387
Raptiva*11152845*
Elidel03519
Protopic05005
Oxsoralen (PUVA)00000

*Although appearing to be the most innocuous of the biologic drugs in the comparison above; Raptiva was removed from the U.S. market on April 8, 2009 due to the risk of PML, a fatal brain infection.

Data compiled using MedWatch statistics available at FDA.gov

Enbrel is a registered trademark of Amgen, Inc. / Wyeth Pharmaceuticals.
Humira is a registered trademark of Abbott Laboratories.
Remicade is a registered trademark of Centocor, Inc.
Raptiva is a registered trademark of Genentech.
Elidel is a registered trademark of Novartis.
Protopic is a registered trademark of Astellas Pharma.